Healio
SearchLoading
Healio
SearchLoading

Professional Communications, Inc.

Professional Communications, Inc. (PCI) is a medical publishing, content development, training and medical education company serving the global life sciences industry. PCI works collaboratively with clients to create the highest quality medical and scientific programs and content. PCI’s co-founder is Malcolm Beasley, who serves as the company’s president.
Choose a Section

Most recent by Professional Communications, Inc.

Learn the Heart

Part of the Healio Network

Sodium-Glucose Transporter 2 (SGLT2) Inhibitors Topic Review

As a class, sodium–glucose transporter 2 inhibitors are novel drugs initially developed for glycemic control in patients with type 2 diabetes. [Cowie MR, et al. Nat Rev Cardiol. 2020;1a]

Learn the Heart

Part of the Healio Network

Icosapent Ethyl Topic Review

Icosapent ethyl is a prescription-grade derivative of the omega-3 fatty acid eicosapentaenoic acid, a component of fish oil.

Learn the Heart

Part of the Healio Network

Bempedoic Acid Topic Review

Bempedoic acid (Nexletol, Esperion Therapeutics) is a nonstatin low-density lipoprotein cholesterol (LDL-C)-lowering drug.

Learn the Heart

Part of the Healio Network

PCSK9 Inhibitors Topic Review

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a protein that binds to the LDL receptor on hepatocytes, promoting its internalization and degradation within the cell. [Repatha package insert;9a]

Learn the Heart

Part of the Healio Network

Aspirin Topic Review

Aspirin (acetylsalicylic acid) is a versatile drug from the salicylate class.

Learn the Heart

Part of the Healio Network

Atherosclerosis Topic Review

Atherosclerosis is a chronic, systemic, inflammatory and metabolic disease and pathologic process characterized by the accumulation of cholesterol and calcium plaque within the arterial wall. [Kobiyama K, et al. Circ Res. 2018;1a]